Premier Alternatives

Ataraxis (Diagnostic Equipment)

New York, NY · Founded 2022 · Privately Held (backing)

Developer of prognostic and predictive digital diagnostic assays designed to help doctors select the optimal treatment for all patients. Ataraxis (Diagnostic Equipment) is based in New York, NY and was founded in 2022. Its last reported valuation was $68 million in Mar 2025. It has raised $24.1 million.

Last reported valuation
$68.0M
Oct 2026
Priced at
—
Total raised
$24.1M
Last round
—

Ataraxis (Diagnostic Equipment) key facts

as of Oct 2026
  • Developer of prognostic and predictive digital diagnostic assays designed to help doctors select the optimal treatment for all patients.
  • Ataraxis (Diagnostic Equipment) is valued at approximately $68.0M as of Oct 2026 (last reported valuation).
  • It has raised $24.1M; the latest was Early Stage VC ($20.0M) in Mar 2025.
  • Notable investors include Transpose Platform Management, Founders Fund, Endless Frontier Labs, AIX Ventures, Obvious Ventures — 12 tracked in total.
  • Status: Privately Held (backing).
Last reported valuation
LOW confidence
$68.0M

Ataraxis (Diagnostic Equipment)'s last reported valuation, Mar 2025. Nothing priced has surfaced since.

set by last reported valuationas of Oct 2026question about this number?
Free account
More of Ataraxis (Diagnostic Equipment) with a free account
  • ·The complete investor list: 12 names
  • ·Watch Ataraxis (Diagnostic Equipment): the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

Ataraxis (Diagnostic Equipment) funding rounds

No rounds on record

No funding rounds for Ataraxis (Diagnostic Equipment) are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.

Pro members can request priority coverage with a 48-hour turnaround.

Ataraxis (Diagnostic Equipment) valuation

Ataraxis (Diagnostic Equipment)'s last reported valuation was $68 million in Mar 2025. No priced round, secondary trade or fund mark has surfaced since.

Ataraxis (Diagnostic Equipment) investors

12 investors are on record for Ataraxis (Diagnostic Equipment), including Transpose Platform Management, Founders Fund, Endless Frontier Labs and AIX Ventures. By type, the record holds 5 venture capital firms.

About Ataraxis (Diagnostic Equipment)

Developer of prognostic and predictive digital diagnostic assays designed to help doctors select the optimal treatment for all patients. The company integrates multi-modal data to deliver accurate, patient-specific predictions about therapeutic outcomes across several diseases, enabling doctors to detect the early stage of breast cancer.

Sector
Healthcare
HQ
New York, NY, United States
Founded
2022
Employees
29
Ownership
Privately Held (backing)

Is this your company? Sign in with your work email to keep it current, or tell us what's wrong.